SARS-CoV-2 (COVID-19) serology: implications for clinical practice, laboratory medicine and public health
- 3 August 2020
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 192 (34), E973-E979
- https://doi.org/10.1503/cmaj.201588
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infectionJournal of Microbiology, Immunology and Infection, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)International Journal of Infectious Diseases, 2020
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020Eurosurveillance, 2020
- Point-of-care testing: A position statement from the Canadian Society of Clinical ChemistsClinical Biochemistry, 2018
- MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015Emerging Infectious Diseases, 2017
- Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infectionVaccine, 2016
- Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus InfectionJournal of Virology, 2014
- T cell-mediated immune response to respiratory coronavirusesImmunologic Research, 2014